Method development · MSK
HostBio / Comp-MRF
I conceived and engineered HostBio, an interpretable probabilistic framework for recovering host-tissue composition from routine CT. The framework is implemented for MSK clinical research and has been evaluated across 1,078 patients in four independent NSCLC cohorts, including randomized RTOG-0617, using immune, genomic, treatment, toxicity, response, and survival data.
1,078 patients · 4 NSCLC cohorts · randomized trial data
Explore HostBio →